期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

调脂药物对糖尿病状态下糖代谢的影响及其机制的研究进展 被引量：14

下载PDF
导出
摘要 2型糖尿病患者常合并有脂代谢异常,单纯控制血糖不能完全消除糖尿病患者发生冠心病等大血管并发症,因此,在控制血糖的同时,必须进行调脂治疗.目前,临床常用的调脂药物主要包括他汀类、贝特类、烟酸、胆固醇吸收抑制剂.在最近发表的CORALL研究中表明,在合并血脂代谢异常的2型糖尿病患者中,大剂量他汀类药物治疗可能会影响患者的血糖控制[1].因此,对合并高脂血症的2型糖尿病患者,应用调脂药物对糖代谢的影响日益受到关注.我们主要介绍各类调脂药物对糖尿病状态下糖代谢的影响及其可能机制.
作者 钟勇 江时森
机构地区 南京军区南京总医院心脏内科
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2013年第9期990-992,共3页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
基金 江苏省自然科学基金(BK2011661)
关键词 糖尿病 降血脂药 烟酸类 氯贝酸 葡萄糖代谢障碍
分类号 R587.1 [医药卫生—内分泌]
  • 相关文献

参考文献28

  • 1Simsek S, Schalkwij k CG, Wolffenbuttel BH. Effects of rosuv astatin and atorvastatin on glycaemie control in type 2 diabe tes the CORALI. study. Diabetic Medicine, 2012, 29:628 631.
  • 2Rizos CV, Milionis H J, Kostapanos MS, et al. Effects of rosu vastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with im paired fasting glucose, hypertension, and mixed hyperlipi demiaa 24-week, randomized, open-label, prospective study. Clin Ther,2010,32:492-505.
  • 3Chen Y,Ohmori K, Mizukawa M, et al. Differential impact of atorvastatin vs pravastatin on progressive insulin resistance and left ventrieular diastolic dysfunction in a rat model of type I1 diabetes. Cire 1,2007.71,144-152.
  • 4Pimpinella G, Bertini Malgarini R, Martini N. Statins for pa tients with type 2 diabetes. Lancet, 2004,364 1933.
  • 5Osaki F,Ikeda S,Suehiro T,et al. Effect of statins on glucose metabolism( in Japanese, with title translated by the au thors). Jpn J Clin Exp Med, 2005,82 : 359-363.
  • 6王礼文,梁社全,冯学山.血脂康对2型糖尿病伴高脂衄症患者血脂、血糖的影响.实用心肺腑杂志,2006,14:530-531.
  • 7杨少勇,周建华.血脂康对老年糖尿病血糖的影响[J].当代医学,2009,15(3):35-36. 被引量：3
  • 8Sasaki J, Iwashita M, Kono S. Statins: beneficial or adverse for glucose metabolism. J Athroscler Thromb, 2006,13 123-129.
  • 9Preiss D, Seshasai SR, Welsh P, et al. Risk of incident diabetes with intensive dose compared with moderate-dose statin ther- apy:a meta-analysis. JAMA,2011,305 2556 2564.
  • 10Krysiak R,Gdula-Dymek A, Okopien B. Effects of simvastatin and fenofibrate on cytokine release and systemic inflammation in type 2 diabetes mellitus with mixed hyperlipidemia. Am J Cardiol, 2011,107 1010-1018.

二级参考文献36

  • 1张刚,沐贤友,曹雪滨,黄雄,毛继康,汪明慧.血脂康和阿托伐他汀治疗混合型高血脂症的研究[J].现代中西医结合杂志,2005,14(2):154-155. 被引量：5
  • 2杨文英,邢小燕,林红,马晓华,胡英华,李光伟,潘孝仁.高甘油三酯血症是非胰岛素依赖型糖尿病发病的危险因素──432例非糖尿病人群六年前瞻性观察[J].中华内科杂志,1995,34(9):583-586. 被引量：143
  • 3Berry C,Tardif JC,Bourassa MG,et al. Coronary heart disease in patients with diabetes. JACC, 2007,49 : 631-642.
  • 4Buse JB, Ginsberg HN, Bakris GI, et al. Primary prevention of cardiovascular disease in people with diabetes mellitus;A scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care, 2007,30 : 162- 172.
  • 5Preventing and managing diabetic complications in elderly patients. Cleve Clin J Med,2008,75:153-158.
  • 6Insull WJr. The pathology of atheroselerosis: plaque development and plaque responses to medical treatment. Am J Med, 2009,122 : S3-S14.
  • 7Buse JB,Bigger JT,Byington RP,et al. Action to Control Cardiovascular Risk in Diabetes(ACCORD) trial:design and methods. Am J Cardiol,2007,99:S21-S33.
  • 8ADVANCE Collaborative Group. Effects of a fixed combination of peridopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus(the ADVANCE trial). Lancet, 2007,370 : 829-840.
  • 9Saremi A, Anderson R J, Luo P, et al. Association between IL-6 and the extent of coronary atherosclerosis in the veterans affairs diabetes trial (VADT). Atherosclerosis, 2009, 203 : 610- 614.
  • 10Lafuma A,Colin X, Solesse A. Cost-effectiveness of atorvasta tin in the prevention of cardiovascular events in diabetic pa tients:A French adaptation of CARDS. Arch Cardiovasc Dis, 2008,101:327-332.

共引文献69

同被引文献152

引证文献14

二级引证文献67

中华老年心脑血管病杂志
2013年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部